Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy.
about
Radiation dose effect in locally advanced non-small cell lung cancerDefinitive radiotherapy in locally advanced non-small cell lung cancer: dose and fractionationLarge volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc.Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen
P2860
Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Toxicity report of a phase 1/2 ...... y and concurrent chemotherapy.
@en
Toxicity report of a phase 1/2 ...... y and concurrent chemotherapy.
@nl
type
label
Toxicity report of a phase 1/2 ...... y and concurrent chemotherapy.
@en
Toxicity report of a phase 1/2 ...... y and concurrent chemotherapy.
@nl
prefLabel
Toxicity report of a phase 1/2 ...... y and concurrent chemotherapy.
@en
Toxicity report of a phase 1/2 ...... y and concurrent chemotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Toxicity report of a phase 1/2 ...... y and concurrent chemotherapy.
@en
P2093
Benedikt Engels
Christine Collen
Denis Schallier
Douwe Verdries
Guy Storme
Harijati Versmessen
Hendrik Everaert
Jacques De Greve
Koen Tournel
Mark De Ridder
P2860
P304
P356
10.1002/CNCR.24732
P407
P577
2010-01-01T00:00:00Z